Insider Buying: ASP Isotopes (NASDAQ:ASPI) Director Acquires $21,600.00 in Stock

ASP Isotopes Inc. (NASDAQ:ASPI) Director John Ryan purchased 8,000 shares of ASP Isotopes stock in a transaction on Monday, September 28th. The stock was bought at an average price of $2.70 per share, with a total value of $21,600.00. Following the transaction, the director owned 660,222 shares of the company’s stock, valued at approximately $1,782,599.40. This represents a 1.23% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Robert John Andrew Ryan also recently made the following trade(s):

• On Wednesday, September 30th, John Ryan acquired 15,000 shares of ASP Isotopes stock. The shares were bought at an average cost of $2.68 per share, for a total transaction of $40,200.00.

ASP Isotopes Trading Up 7.8%

Shares of NASDAQ:ASPI opened at $2.91 on Friday. The stock has a 50 day moving average of $3.70 and a 200 day moving average of $4.88. The company has a market cap of $446.13 million, a PE ratio of -2.20 and a beta of 3.69. ASP Isotopes Inc. has a 12-month low of $2.51 and a 12-month high of $14.49. The company has a current ratio of 3.87, a quick ratio of 3.85 and a debt-to-equity ratio of 0.76.

ASP Isotopes (NASDAQ:ASPI) last released its earnings results on Friday, August 14th. The company reported ($0.28) EPS for the quarter, missing analysts’ consensus estimates of ($0.17) by ($0.11). ASP Isotopes had a negative return on equity of 64.99% and a negative net margin of 427.98%.The firm had revenue of $5.12 million for the quarter, compared to the consensus estimate of $4.47 million.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the business. BlackRock Inc. bought a new position in ASP Isotopes in the 2nd quarter worth approximately $57,331,000. Encompass Capital Advisors LLC bought a new stake in shares of ASP Isotopes during the first quarter valued at approximately $30,551,000. AWM Investment Company Inc. purchased a new position in shares of ASP Isotopes in the second quarter worth $9,837,000. Philadelphia Financial Management of San Francisco LLC purchased a new position in shares of ASP Isotopes in the second quarter worth $8,353,504. Finally, Man Group plc purchased a new position in shares of ASP Isotopes in the second quarter worth $5,153,000. 16.80% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on ASPI. Weiss Ratings restated a “sell (d-)” rating on shares of ASP Isotopes in a research report on Monday, September 21st. Wall Street Zen raised shares of ASP Isotopes from a “strong sell” rating to a “sell” rating in a report on Saturday, August 22nd. Two research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $13.00.

About ASP Isotopes

ASP Isotopes Inc (NASDAQ: ASPI) is a development-stage company focused on isotope enrichment and related technologies. The company is developing an isotope-separation platform known as the Aerodynamic Separation Process, which is intended to enrich selected chemical elements and isotopes for use in several specialized markets.

ASP Isotopes has identified applications in the nuclear energy, medical, semiconductor, and quantum-computing industries. Its development programs have included uranium enrichment as well as the production of specialty isotopes such as carbon-14, molybdenum-100, and silicon-28.